To define the functional involvement of Prmt1 in leukemias, we performed a systematic functional screen by retroviral transduction and transformation assay (RTTA) using validated Prmt1 small hairpin RNAs (shRNAs) on more than ten different MLL and non-MLL oncogenic transcription factors. This evidence concerns the gene KMT2A and leukemia.